RVX297
RVX297 is a BD2 selective inhibitor of BET bromodomains. It is structurally related to the clinical compound RVX-208. It has significant implications on differential gene expression, which possibly can be further linked to the specific disease indication. It is currently undergoing phase III clinical trials for the treatment of cardiovascular diseases.
| Supplier | BOC Sciences |
|---|---|
| Product # | 1044871-04-6 |
| Pricing | Inquire |
| Cas | 1044871-04-6 |
| Molecular Weight | 423.51 |
| Molecular Formula | C24H29N3O4 |